CITRASATE C4125 SOLUTION

Χώρα: Καναδάς

Γλώσσα: Αγγλικά

Πηγή: Health Canada

Δραστική ουσία:

POTASSIUM CHLORIDE; SODIUM CHLORIDE; CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; DEXTROSE; CITRIC ACID; SODIUM ACETATE

Διαθέσιμο από:

CHIEF MEDICAL SUPPLIES LTD

Φαρμακολογική κατηγορία (ATC):

B05ZA

INN (Διεθνής Όνομα):

HEMODIALYTICS, CONCENTRATES

Δοσολογία:

13.47G; 263G; 6.24G; 2.14G; 49.5G; 6.91G; 1.11G

Φαρμακοτεχνική μορφή:

SOLUTION

Σύνθεση:

POTASSIUM CHLORIDE 13.47G; SODIUM CHLORIDE 263G; CALCIUM CHLORIDE 6.24G; MAGNESIUM CHLORIDE 2.14G; DEXTROSE 49.5G; CITRIC ACID 6.91G; SODIUM ACETATE 1.11G

Οδός χορήγησης:

HAEMODIALYSIS

Μονάδες σε πακέτο:

4.5L

Τρόπος διάθεσης:

Ethical

Θεραπευτική περιοχή:

HEMODIALYSIS SOLUTION

Περίληψη προϊόντος:

Active ingredient group (AIG) number: 0752576005; AHFS:

Καθεστώς αδειοδότησης:

MARKETED

Ημερομηνία της άδειας:

2013-03-01

Αρχείο Π.Χ.Π.

Page 1 of 7
PRODUCT MONOGRAPH
CITRASATE
® C4125
Haemodialysis Solution, BP
Sodium Chloride
263 g / L
Potassium Chloride
13.47 g / L
Calcium Chloride
6.24 g / L
Magnesium Chloride
2.14 g / L
Citric Acid
6.91 g / L
Sodium Acetate
1.11 g / L
Glucose Monohydrate
49.5 g / L
CHIEF MEDICAL SUPPLIES LTD.
DATE OF REVISION:
411-19
th
Street S.E.
January 14, 2021
Calgary Alberta T2E 6J7
CONTROL NO.: 242801
Page 2 of 7
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION………………………...
3
SUMMARY PRODUCT
INFORMATION……………………………………...
3
INDICATIONS AND CLINICAL
USE…………………………………………
3
CONTRAINDICATIONS……………………………………………………….
3
WARNINGS AND
PRECAUTIONS……………………………………………
4
ADVERSE
REACTIONS………………………………………………………..
4
DRUG
INTERACTIONS………………………………………………………...
4
DOSAGE AND
ADMINISTRATION…………………………………………..
4
OVERDOSAGE………………………………………………………………….
5
ACTIONS AND CLINCAL PHARMACOLOGY………………………………
6
STORAGE AND
STABILITY…………………………………………………...
6
DOSAGE FORMS, COMPOSITION AND PACKAGING……………………..
6
REFERENCES……………………………………………………………………
6
MORE
INFORMATION…………………………………………………………
7
Page 3 of 7
CITRASATE
® C4125
Haemodialysis Solution, BP
PART I: HEALTH PROFESSIONAL INFORMATION
SUMMARY PRODUCT INFORMATION
ROUTE OF ADMINISTRATION
DOSAGE FORM / STRENGTH
CLINICALLY RELEVANT NON-
MEDICINAL INGREDIENTS
Hemodialysis
Concentrated solution
Sodium Chloride 263 g / L
Potassium Chloride
13.47 g / L
Calcium Chloride 6.24 g / L
Magnesium Chloride 2.14 g / L
Citric Acid 6.91 g / L
Sodium Acetate 1.11 g / L
Glucose Monohydrate 49.5 g / L
None
INDICATIONS AND CLINICAL USE
Citrasate